MEDICINE

The death of celebrity disc jockey DJ AM was caused by an accidental drug overdose, and eight different substances were found in his body, the New York City Medical Examiner's office said on Tuesday.

Part of the appeal of electronic medical records is that they can help doctors keep track of test results and avoid medical errors, but a study released on Monday suggests that doctors sometimes ignore electronic warnings about abnormal test results.

Doctors do not involve men enough in discussions about whether to undergo screening for prostate cancer, U.S. researchers reported on Monday.

A teenage British girl died after receiving a cervical cancer vaccine made by GlaxoSmithKline, but a link between the death and the drug has not yet been established, health officials said on Monday.

U.S. health officials are looking into whether patients with a certain bone marrow disorder are more at risk for death and serious complications with the drug Exjade, made by Novartis AG.

A small but growing number of women with breast cancer are choosing to have the unaffected breast removed in an effort to prevent a recurrence, researchers reported Monday.

The world's two largest diversified healthcare companies struck deals on Monday that will propel them into vaccines, a red-hot area for investors because of the pandemic flu threat and potential high profits for preventing other diseases.

Alcohol abuse, obesity and depression seem to go hand in hand for many women, according to the first study to look at how the three relate to one another over time in young adults.

A top U.S. health official says the first weeks of October are going to be a little bumpy as the government distributes the supply theswine flu vaccine ready next week -- knowing it will not be enough.

Screening all men for prostate cancer using a currently available common blood test is not worthwhile, according to a new study.

U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday, aimed at securing vaccines and other products key to future growth.

An experimental AIDS vaccine that appears to be the first to protect people was mired for years in controversy, and credit for its success must go to Thailand where the trial was conducted, experts said.

Drugmaker Merck & Co has gained rights to sell and distribute CSL Ltd's seasonal flu vaccine in the United States under an agreement announced by the companies on Monday.

U.S. diversified health care company Johnson & Johnson has bought an 18 percent stake in biotech firm Crucell for 302 million euros ($444 million) as part of a flu vaccine development deal, the Dutch company said on Monday.

U.S. healthcare companies Abbott Laboratories and Johnson & Johnson announced deals worth almost 5 billion euros ($7.3 billion) with European rivals on Monday aimed at securing vaccines and other products key to future growth.

Early detection of problems in the lymphatic system is the best way to prevent the discomfort and disfigurement that can result from lymphoedema, the swelling created by disruption to the body's drainage system.

Dutch biotechnology firm Crucell said on Monday Johnson & Johnson had bought 14.6 million new Crucell shares for 302 million euros ($443.5 million) as part of a flu vaccine development deal.

U.S. drugmaker Abbott Laboratories plans to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros), two sources familiar with the situation said on Sunday, with an announcement expected on Monday.

U.S. drugmaker Abbott Laboratories plans to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros), two sources familiar with the situation said on Sunday, with an announcement expected on Monday.

U.S. drugmaker Abbott Laboratories is planning to buy Solvay SA's pharmaceuticals unit for $6.6 billion (4.5 billion euros) in cash, with an announcement expected in the next 24 hours, a source familiar with the situation said on Sunday.

Australia's health system is failing the many people who suffer from multiple illnesses as it is principally designed to deal with individual conditions, a new study suggests.